Answers are grounded in this paper and cite their sources.
Many of the analgesics which are utilized in efforts to diminish pain act on G-protein, coupled receptors (GPCRs) to initiate/activate a number of second messenger effects and signaling pathways. It is conceivable that the direct or indirect manipulation/modulation of small GT Pases and other associated enzymes/proteins which act downstream from GPCRs may be useful as analgesic adjuncts which may lead to increased efficacy or decreased adverse effects.
No takes yet. Share an insight, caveat, or question.
Howard S. Smith (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: